B
Bull
Bull · 25%COCH
$1.15
Precio del escenario
$0.690
-0.039 (-5.58%)Al cierre
Loading chart…
- High
- 0.759
- Open
- 0.759
- VWAP
- 0.71
- Vol
- 49.04K
- Mkt Cap
- 44.88M
- Low
- 0.690
- Amount
- 34.97K
- EV/EBITDA, TTM
- -1.12
Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.
AI analysis of Envoy Medical Inc (COCH)
holdCurrently, Envoy Medical Inc (COCH) is not a strong buy due to its low current price of $0.69, a significantly negative RSI of 25.366, and a concerning 1-year change of -46.50%. While analysts have a price target of $2, indicating potential upside, the company's ongoing losses and negative gross margins raise substantial risks.
Métricas de valoración
The current forward P/E ratio for Envoy Medical Inc (COCH) is 0.00, compared to its 5-year average forward P/E of -1.83.
Alphio AI Price Scenarios for COCH
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Cronología de eventos
Noticias
1.006-26GlobenewswireVirtual Investor Conferences Forum Highlights
8.506-25seekingalphaEnvoy Medical Terminates ATM Equity Facility, Impacting Future Capital Raising
- 1.006-23Globenewswire
Agenda Announced for Life Sciences Virtual Investor Forum
- 9.503-23seekingalpha
Envoy Medical Reports FY 2025 Financial Results
- 8.502-24seekingalpha
Envoy Medical Regains Nasdaq Compliance
COCH FAQ — answered by Alphio AI
Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss. It operates in the Healthcare sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).
Currently, Envoy Medical Inc (COCH) is not a strong buy due to its low current price of $0.69, a significantly negative RSI of 25.366, and a concerning 1-year change of -46.50%. While analysts have a price target of $2, indicating potential upside, the company's ongoing losses and negative gross margins raise substantial risks.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.